Humanity vs. Disease: The Ultimate War for Survival – Who Will Win in the End? Part 3
5. Research Case Study 2: Genetic Eradication of Monogenic Blood Disorders The clinical clearance and commercial deployment of CRISPR-Cas9 genome editing therapies represent a monumental shift in therapeutic paradigms. For decades, modern medicine focused almost exclusively on palliative interventions—managing symptoms, mitigating cellular damage, and administering lifelong maintenance…







